- Home
- INM vs SIGIP Comparison
INM vs SIGIP Comparison
Compare INM & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INM | SIGIP |
|---|---|---|
| Founded | 1981 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | N/A |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | INM | SIGIP |
|---|---|---|
| Price | $1.39 | $15.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 70.4K | 7.8K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.68 | ★ 131.89 |
| EPS | N/A | ★ 3.69 |
| Revenue | $4,942,633.00 | ★ $5,336,928,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.17 |
| Revenue Growth | 7.50 | ★ 9.78 |
| 52 Week Low | $0.58 | $14.80 |
| 52 Week High | $2.50 | $18.71 |
Technical Indicators
Market Signals| Indicator | INM | SIGIP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 44.35 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $16.05 |
| Average True Range (ATR) | 0.00 | 0.26 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 62.11 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.